TABLE OF CONTENTS
Volume 25, Issue 23 (1 June 2006)
Original Articles
Erasure of methylation imprint at the promoter and CTCF-binding site upstream of H19 in human testicular germ cell tumors of adolescents indicate their fetal germ cell origin FREE
T Kawakami, C Zhang, Y Okada and K Okamoto
Oncogene 25: 3225-3236; advance online publication, January 23, 2006; doi:10.1038/sj.onc.1209362
Integrin-linked kinase activity is associated with interleukin-1
-induced progressive behavior of pancreatic cancer and poor patient survival FREE
H Sawai, Y Okada, H Funahashi, Y Matsuo, H Takahashi, H Takeyama and T Manabe
Oncogene 25: 3237-3246; advance online publication, January 16, 2006; doi:10.1038/sj.onc.1209356
The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis FREE
N Moniaux, C Nemos, B M Schmied, S C Chauhan, S Deb, K Morikane, A Choudhury, M VanLith, M Sutherlin, J M Sikela, M A Hollingsworth and S K Batra
Oncogene 25: 3247-3257; advance online publication, February 20, 2006; doi:10.1038/sj.onc.1209353
E2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts
F M Frame, H A Rogoff, M T Pickering, W D Cress and T F Kowalik
Oncogene 25: 3258-3266; advance online publication, January 23, 2006; doi:10.1038/sj.onc.1209352
C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells
M-C Huang, H-Y Chen, H-C Huang, J Huang, J-T Liang, T-L Shen, N-Y Lin, C-C Ho, I-M Cho and S-M Hsu
Oncogene 25: 3267-3276; advance online publication, January 16, 2006; doi:10.1038/sj.onc.1209350
Hypoxia induced by benign intestinal epithelial cells is associated with cyclooxygenase-2 expression in stromal cells through AP-1-dependent pathway
Y Uenoyama, H Seno, A Fukuda, A Sekikawa, A Nanakin, T Sawabu, M Kawada, N Kanda, K Suzuki, N Yada, H Fukui and T Chiba
Oncogene 25: 3277-3285; advance online publication, January 23, 2006; doi:10.1038/sj.onc.1209359
Upregulation and activation of PKC by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC and Src inhibitors
M Tan, P Li, M Sun, G Yin and D Yu
Oncogene 25: 3286-3295; advance online publication, January 23, 2006; doi:10.1038/sj.onc.1209361
The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter
Y Li, M Xie, J Yang, D Yang, R Deng, Y Wan and B Yan
Oncogene 25: 3296-3306; advance online publication, February 6, 2006; doi:10.1038/sj.onc.1209363
B-Raf and C-Raf are required for Ras-stimulated p42 MAP kinase activation in Xenopus egg extracts
J Yue, W Xiong and J E Ferrell Jr
Oncogene 25: 3307-3315; advance online publication, January 23, 2006; doi:10.1038/sj.onc.1209354
Increased megakaryocytopoiesis in Lyn-deficient mice
B J Lannutti, J Minear, N Blake and J G Drachman
Oncogene 25: 3316-3324; advance online publication, January 16, 2006; doi:10.1038/sj.onc.1209351
Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors
M D Landis, D D Seachrist, F W Abdul-Karim and R A Keri
Oncogene 25: 3325-3334; advance online publication, January 23, 2006; doi:10.1038/sj.onc.1209365
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer
S Chattopadhyay, R Machado-Pinilla, C Manguan-García, C Belda-Iniesta, C Moratilla, P Cejas, J A Fresno-Vara, J de Castro-Carpeño, E Casado, M Nistal, M Gonzalez-Barón and R Perona
Oncogene 25: 3335-3345; advance online publication, February 6, 2006; doi:10.1038/sj.onc.1209364
Oncogenomics
Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis
S Wang, M Zhan, J Yin, J M Abraham, Y Mori, F Sato, Y Xu, A Olaru, A T Berki, H Li, K Schulmann, T Kan, J P Hamilton, B Paun, M M Yu, Z Jin, Y Cheng, T Ito, C Mantzur, B D Greenwald and S J Meltzer
Oncogene 25: 3346-3356; advance online publication, January 30, 2006; doi:10.1038/sj.onc.1209357
